Roughly 1 in 8 US adults have taken GLP-1 drugs like Wegovy, poll shows
(Reuters) – About one in eight adults have taken a drug belonging to the GLP-1...
(Reuters) – About one in eight adults have taken a drug belonging to the GLP-1...
By Jarrett Renshaw and Trevor Hunnicutt (Reuters) – The Biden administration is expected to issue...
By Blake Brittain (Reuters) – Apple urged a U.S. appeals court on Friday to overturn...
By Puyaan Singh (Reuters) -Abbott Laboratories said on Tuesday the U.S. FDA has approved its...
By Dietrich Knauth NEW YORK (Reuters) – Rite Aid, one of the largest U.S. pharmacy...
(Reuters) -The U.S. Centers for Disease Control and Prevention issued an advisory on Thursday alerting...
(Reuters) -U.S. prosecutors in Virginia are probing whether Facebook-parent Meta’s social media platforms facilitated and...
By Patrick Wingrove and Sriparna Roy (Reuters) -The U.S. Food and Drug Administration approved Novo...
(Reuters) – The U.N. agency for Palestinian refugees said some employees released into Gaza from...
FRANKFURT (Reuters) -German drugmaker Bayer said on Monday that it was amending its dividend policy...